Aura Biosciences Inc. AURA
$6.25
▲ +3.22% 24H
About
Aura Biosciences Inc. is a clinical-stage biotechnology company developing precision immunotherapies for solid tumors, designed to preserve organ function in cancer patients. The company leverages a proprietary platform using virus-like particles, or VLPs, conjugated with drugs or loaded with nucleic acids to create vi…
SectorHealthcare
ExchangeNASDAQ
IndustryBiotechnology
CountryUnited States
Employees113
TickerAURA
Statistics
Market Cap$400.6M
Revenue (TTM)—
Net Income-$106.2M
Net Margin—
EPS$-1.76
P/E-3.56
P/S—
P/B3.71
EV/EBITDA-4.63
ROE-95.6%
Dividend Yield—
Price$6.25
Data: Twelve Data · Revenue = mcap / P/S